Abnormal liver steatosis and fibrosis serum biomarker levels among psychiatric inpatients

•there is a gap in the field of hepatic steatosis research in the mentally ill population.•psychiatric inpatients seem to be prone to the liver steatosis and fibrosis development.•the use of atypical antipsychotics can result in fatty liver and risk of fibrosis.•results of this study should be consi...

Full description

Saved in:
Bibliographic Details
Published inClinics and research in hepatology and gastroenterology Vol. 48; no. 6; p. 102366
Main Authors Rogalski, Jakub, Czarnecka-Chrebelska, Karolina, Węglewska, Kinga, Płeska, Kacper, Gawlik-Kotelnicka, Oliwia
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.06.2024
Subjects
Antipsychotics
Biomarkers
Liver fibrosis
Mental disorders
Non-alcoholic fatty liver disease
Biomarkers
Antipsychotics
Liver fibrosis
Mental disorders
Non-alcoholic fatty liver disease
Online AccessGet full text

Cover

More Information
Summary:•there is a gap in the field of hepatic steatosis research in the mentally ill population.•psychiatric inpatients seem to be prone to the liver steatosis and fibrosis development.•the use of atypical antipsychotics can result in fatty liver and risk of fibrosis.•results of this study should be considered as a rationale for future research.
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:2210-7401
2210-741X
2210-741X
DOI:10.1016/j.clinre.2024.102366